Meet
Features
Solutions
Pricing
Sales Intelligence
Qualify prospects and connect with decision makers effortlessly
Research Companies & Directors
Make important decisions with absolute confidence
Create B2B Marketing Lists
Target and reach more of your ideal prospects than ever
Monitor Risks & Opportunities
Be the first to learn about changes in the companies that matter
Cleanse Your B2B Database
Instantly transform old records into new opportunities
Perform KYC Checks
Completely understand who you're working with
Discover New Businesses
Identify and connect with new companies as soon as they register
Company Credit Reports
See how companies are performing year–on–year and explore their debts
UPGRADE
Contact
Credit Report
Financials
People
Ownership
Latest Activity
Mutual Companies
Documents
Repayment History
Envision Pharma Limited
Envision Pharma Limited is an active company incorporated on 15 July 2002 with the registered office located in Horsham, West Sussex. Envision Pharma Limited was registered 23 years ago.
Watch Company
Status
Active
Active since
incorporation
Company No
04486293
Private limited company
Age
23 years
Incorporated
15 July 2002
Size
Unreported
Confirmation
Submitted
Dated
16 July 2025
(3 months ago)
Next confirmation dated
16 July 2026
Due by
30 July 2026
(9 months remaining)
Last change occurred
9 years ago
Accounts
Submitted
For period
1 Jan
⟶
31 Dec 2023
(12 months)
Accounts type is
Audit Exemption Subsidiary
Next accounts for period
31 December 2024
Due by
31 December 2025
(1 month remaining)
Learn more about Envision Pharma Limited
Contact
Update Details
Address
Envision House
5 North Street
Horsham
West Sussex
RH12 1XQ
Address changed on
27 Jun 2022
(3 years ago)
Previous address was
Companies in RH12 1XQ
Telephone
01403322000
Email
Available in Endole App
Website
Envisionpharmagroup.com
See All Contacts
People
Officers
4
Shareholders
1
Controllers (PSC)
1
Mr Adam Brent Deutsch
Director • American • Lives in United States • Born in Dec 1970
Howard Collins Miller Iii
Director • Ceo • American • Lives in United States • Born in Jul 1956
Joshua Hollis Korth
Director • American • Lives in United States • Born in Jan 1975
Stanford Benjamin Rudnick
Director • American • Lives in United States • Born in Aug 1983
Envision Pharma Holdco Limited
PSC
See Key People
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
See All Shareholders, PSCs & Group Structure
Mutual Companies
90ten Ltd
Stanford Benjamin Rudnick, Joshua Hollis Korth, and 2 more are mutual people.
Active
Curo Consulting Limited
Stanford Benjamin Rudnick, Joshua Hollis Korth, and 2 more are mutual people.
Active
Touch Creative Design Limited
Stanford Benjamin Rudnick, Joshua Hollis Korth, and 2 more are mutual people.
Active
Engage Scientific Solutions Limited
Stanford Benjamin Rudnick, Joshua Hollis Korth, and 2 more are mutual people.
Active
Evidence Scientific Solutions Limited
Stanford Benjamin Rudnick, Joshua Hollis Korth, and 2 more are mutual people.
Active
Envision Pharma Holdco Limited
Stanford Benjamin Rudnick, Joshua Hollis Korth, and 2 more are mutual people.
Active
Excel Scientific Solutions Limited
Stanford Benjamin Rudnick, Joshua Hollis Korth, and 2 more are mutual people.
Active
90ten Group Limited
Mr Adam Brent Deutsch, Stanford Benjamin Rudnick, and 2 more are mutual people.
Active
See All Mutual Companies
Financials
Net Assets, Total Assets & Total Liabilities (2014–2023)
Period Ended
31 Dec 2023
For period
31 Dec
⟶
31 Dec 2023
Traded for
12 months
Cash in Bank
£1.98M
Decreased by £431K (-18%)
Turnover
£7.62M
Increased by £2.48M (+48%)
Employees
404
Increased by 288 (+248%)
Total Assets
£132.79M
Increased by £35.45M (+36%)
Total Liabilities
-£168.85M
Increased by £36.79M (+28%)
Net Assets
-£36.05M
Decreased by £1.34M (+4%)
Debt Ratio (%)
127%
Decreased by 8.51% (-6%)
See 10 Year Full Financials
Latest Activity
Confirmation Submitted
3 Months Ago on 21 Jul 2025
Howard Collins Miller Iii Resigned
10 Months Ago on 31 Dec 2024
Stanford Benjamin Rudnick Details Changed
10 Months Ago on 9 Dec 2024
Stanford Benjamin Rudnick Appointed
10 Months Ago on 9 Dec 2024
Joshua Hollis Korth Resigned
11 Months Ago on 15 Nov 2024
Subsidiary Accounts Submitted
1 Year Ago on 9 Oct 2024
Mr. Adam Brent Deutsch Appointed
1 Year 2 Months Ago on 20 Aug 2024
Confirmation Submitted
1 Year 3 Months Ago on 23 Jul 2024
Joshua Hollis Korth Details Changed
3 Years Ago on 14 Dec 2021
Envision Pharma Holdco Limited (PSC) Details Changed
9 Years Ago on 16 Jul 2016
Get Alerts
Get Credit Report
Discover Envision Pharma Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
See All Credit Score & Limits
Documents
Confirmation statement made on 16 July 2025 with no updates
Submitted on 21 Jul 2025
Director's details changed for Stanford Benjamin Rudnick on 9 December 2024
Submitted on 28 Feb 2025
Appointment of Stanford Benjamin Rudnick as a director on 9 December 2024
Submitted on 10 Feb 2025
Termination of appointment of Howard Collins Miller Iii as a director on 31 December 2024
Submitted on 24 Jan 2025
Termination of appointment of Joshua Hollis Korth as a director on 15 November 2024
Submitted on 24 Jan 2025
Appointment of Mr. Adam Brent Deutsch as a director on 20 August 2024
Submitted on 29 Oct 2024
Audit exemption subsidiary accounts made up to 31 December 2023
Submitted on 9 Oct 2024
Audit exemption statement of guarantee by parent company for period ending 31/12/23
Submitted on 9 Oct 2024
Consolidated accounts of parent company for subsidiary company period ending 31/12/23
Submitted on 9 Oct 2024
Notice of agreement to exemption from audit of accounts for period ending 31/12/23
Submitted on 9 Oct 2024
Explore All Documents
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
See All Charges & CCJs